APT Medical Inc. (688617.SS)
CNY 359.11
(-1.08%)
CNY 359.11
(-1.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 708.87 Million | 367.45 Million | 181.38 Million | 148.24 Million | 54.89 Million | 18.63 Million |
| Net Income | 533.92 Million | 340.15 Million | 194.85 Million | 104.19 Million | 78.07 Million | 16.67 Million |
| Depreciation & Amortization | 67.89 Million | 48.26 Million | 33.44 Million | 20 Million | 14.68 Million | 9.12 Million |
| Deferred income taxes | -4.9 Million | 939.19 Thousand | -8.19 Million | -306.71 Thousand | -565.33 Thousand | -5900.00 |
| Stock-based compensation | 18.31 Million | 20.14 Million | 17.19 Million | - | 2.57 Million | 27.92 Million |
| Change in working capital | 121.39 Million | -33.1 Million | -45.6 Million | 22.1 Million | -42.87 Million | -37.04 Million |
| Other non-cash items | 26.23 Million | -10.54 Million | -10.29 Million | 1.93 Million | 3 Million | 29.88 Million |
| Investing Cash Flow | 372.9 Million | -134.52 Million | -1.11 Billion | 730.12 Thousand | -68.02 Million | -28.6 Million |
| Investments in PPE | -202.02 Million | -143.2 Million | -167.37 Million | -44.2 Million | -67.56 Million | -32.19 Million |
| Acquisitions | -222.88 Million | -182.8 Million | 36.03 Thousand | 11.99 Thousand | 68.39 Million | 386.68 Thousand |
| Investment purchases | -638.82 Million | -1.75 Billion | -1.31 Billion | -44 Million | -23 Million | -57.37 Million |
| Sales/Maturities of investments | 1.43 Billion | 1.76 Billion | 373.16 Million | 14.21 Million | 21.7 Million | 59.88 Million |
| Other Investing Activities | -2.00 | 183.03 Million | -4.99 Million | 74.7 Million | -67.56 Million | 684.34 Thousand |
| Financing Cash Flow | -246.35 Million | -294.59 Million | 1.11 Billion | -101.61 Million | -3.23 Million | 20.89 Million |
| Debt repayment | -20.37 Million | -75.87 Million | -30.27 Million | -115.18 Million | -13.2 Million | -5.5 Million |
| Dividends payments | -109.49 Million | -66.67 Million | -33.33 Million | -1.41 Million | -5.96 Million | -268.26 Thousand |
| Common Stock Repurchased | - | -59.99 Million | - | - | - | - |
| Common Stock Issuance | - | 59.99 Million | - | - | - | - |
| Other Financing Activities | -154.51 Million | -149.71 Million | 1.18 Billion | 14.98 Million | 15.93 Million | 26.66 Million |
| Accounts receivables | 19.99 Million | -23.16 Million | 4.29 Million | 25.33 Million | -60.55 Million | 4.14 Million |
| Accounts payables | 68.9 Million | 61.71 Million | 82.51 Million | -477.46 Thousand | 80.98 Million | -4.63 Million |
| Inventory | 11.21 Million | -72.58 Million | -124.21 Million | -2.43 Million | -62.73 Million | -36.54 Million |
| Other working capital | 21.27 Million | 939.19 Thousand | -8.19 Million | -306.71 Thousand | -565.33 Thousand | -504.87 Thousand |
| Cash at beginning of period | 250.88 Million | 309.66 Million | 120.34 Million | 73.51 Million | 90.75 Million | 79.38 Million |
| Cash at end of period | 1.27 Billion | 248.95 Million | 309.66 Million | 120.34 Million | 73.51 Million | 90.75 Million |
| Capital Expenditure | -202.02 Million | -143.2 Million | -167.37 Million | -44.2 Million | -67.56 Million | -32.19 Million |
| Effect of forex changes on cash | 2.83 Million | 958.23 Thousand | -1.01 Million | -527.35 Thousand | -882.71 Thousand | 451.28 Thousand |
| Net cash flow / Change in cash | 1.02 Billion | -60.7 Million | 189.31 Million | 46.82 Million | -17.23 Million | 11.37 Million |
| Free Cash Flow | 506.84 Million | 224.25 Million | 14.01 Million | 104.03 Million | -12.66 Million | -13.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 185.58 Million | 202.41 Million | 140.14 Million | 130.67 Million | 533.92 Million | 145.85 Million |
| Depreciation & Amortization | - | 20.92 Million | 20.92 Million | 18.59 Million | 67.89 Million | -28.68 Million |
| Deferred income taxes | - | -2.55 Million | - | -70.8 Million | -4.9 Million | 66.94 Million |
| Stock-based compensation | - | 3.63 Million | - | 18.31 Million | 18.31 Million | -9.55 Million |
| Change in working capital | - | -44.02 Million | - | 52.49 Million | 121.39 Million | -31.68 Million |
| Other non-cash items | -3.48 Million | 51.94 Million | -24.47 Million | 62.91 Million | 26.23 Million | 10.38 Million |
| Investing Cash Flow | -161.31 Million | -231.86 Million | -664.8 Million | 432.95 Million | 372.9 Million | -369.76 Million |
| Investments in PPE | -92.42 Million | -342.1 Million | -123.4 Million | -65.94 Million | -202.02 Million | -53.06 Million |
| Acquisitions | 177.19 Million | -176.76 Million | - | -188.41 Million | -222.88 Million | 188.49 Million |
| Investment purchases | -243.75 Million | 282.18 Million | -620.43 Million | 424.71 Million | -638.82 Million | -437.11 Million |
| Sales/Maturities of investments | 73.8 Million | 104.81 Million | 79.02 Million | 262.6 Million | 1.43 Billion | 109.1 Million |
| Other Investing Activities | 101.06 Million | -100 Million | -540.32 Million | -1.00 | -2.00 | -177.17 Million |
| Financing Cash Flow | -136.93 Million | 66.82 Million | -73.11 Million | -7.39 Million | -246.35 Million | -48.25 Million |
| Debt repayment | -295.5 Thousand | -295.5 Thousand | -70.29 Million | -15.73 Million | -20.37 Million | -28.84 Million |
| Dividends payments | -133.82 Million | -133.09 Million | -117.65 Thousand | -109.49 Million | -109.49 Million | -109.49 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -69.75 Million | 69.75 Million | - | - | - | -32.79 Million |
| Other Financing Activities | -2.8 Million | 135.78 Million | -2.81 Million | 8.69 Million | -154.51 Million | -18.82 Million |
| Accounts receivables | - | -9.25 Million | - | 19.99 Million | 19.99 Million | -33.25 Million |
| Accounts payables | - | - | - | - | 68.9 Million | 12.01 Million |
| Inventory | - | -38.36 Million | - | 11.21 Million | 11.21 Million | 1.57 Million |
| Other working capital | - | 3.59 Million | - | 21.27 Million | 21.27 Million | -12.01 Million |
| Cash at beginning of period | 721.02 Million | 654.17 Million | 1.27 Billion | 451.53 Million | 250.88 Million | 717.22 Million |
| Cash at end of period | 599.61 Million | 821.99 Million | 654.17 Million | 1.27 Billion | 1.27 Billion | 451.53 Million |
| Capital Expenditure | -92.42 Million | -342.1 Million | -123.4 Million | -65.94 Million | -202.02 Million | -53.06 Million |
| Effect of forex changes on cash | -3.51 Million | 1 Million | 34.97 Thousand | -2.05 Million | 2.83 Million | -916.32 Thousand |
| Net cash flow / Change in cash | -121.4 Million | 167.81 Million | -622.21 Million | 824.86 Million | 1.02 Billion | -265.69 Million |
| Free Cash Flow | 89.67 Million | -111.22 Million | -7.73 Million | 146.23 Million | 506.84 Million | 100.17 Million |
ALHUN
PENINLAND
EXROF
HBOR3
3166
KANDAGIRI